Comparison of tissue harvest protocols for the quantitation of acylcarnitines in mouse heart and liver by mass spectrometry

Metabolomics

Volumn 8, Issue 5, 2012, Pages 784-792

  Petucci, Christopher ^a   Rojas Betancourt, Stella ^a   Gardell, Stephen J ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Acylcarnitines; Mass spectrometry; Tissue harvest; Tissue processing

Indexed keywords

ACETYLCARNITINE; ACYLCARNITINE; BUTYRYLCARNITINE; CARBON DIOXIDE; DECANOYLCARNITINE; HEXONYLCARNITINE; ISOFLURANE; ISOVALERYLCARNITINE; KETAMINE; LAUROYLCARNITINE; MYRISTOYLCARNITINE; OCTANOYLCARNITINE; PALMITOYLCARNITINE; PENTOBARBITAL; PROPIONYLCARNITINE; STEAROYLCARNITINE; UNCLASSIFIED DRUG; XYLAZINE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CERVICAL SPINE DISLOCATION; CONTROLLED STUDY; EUTHANASIA; FEMALE; FREEZING; HEART; INTERMETHOD COMPARISON; LIVER; MASS SPECTROMETRY; MOUSE; NONHUMAN; SEDATION; SURGICAL TECHNIQUE;

ANIMALIA; MUS;

EID: 84867189072     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0370-8     Document Type: Article

References (37)

1. Álvarez-Sánchez, B., Priego-Capote, F., & Luque de Castro, M. D. (2010). Metabolomics analysis II. Preparation of biological samples prior to detection. TrAC Trends in Analytical Chemistry, 29, 120-127.
2. An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., et al. (2004). Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nature Medicine, 10, 268-274.
3. Bain, J. R., Stevens, R. D., Wenner, B. R., Ilkayeva, O., Muoio, D. M., & Newgard, C. B. (2009). Metabolomics applied to diabetes research; Moving from information to knowledge. Diabetes, 58, 2429-2443.
4. Beger, R. D., Sun, J., & Schnackenberg, L. K. (2010). Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicology and Applied Pharmacology, 243, 154-166.
5. Brass, E. P., & Hoppel, C. L. (1981). In vivo studies of carnitine and fatty acid metabolism: Problems with the use of anesthetics. Analytical Biochemistry, 110, 77-81.
6. Bremer, J. (1990). The role of carnitine in intracellular metabolism. Journal of Clinical Chemistry and Clinical Biochemistry, 28, 297-301.
7. Bruce, S. J., Tavazzi, I., Parisod, V., Rezzi, S., Kochhar, S., & Guy, P. A. (2009). Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Analytical Chemistry, 81, 3285-3296.
8. Camina, M. F., Rozas, I., Gomez, M., Paz, J. M., Alonso, C., & Rodriguez-Segade, S. (1991). Short-term effects of administration of anticonvulsant drugs on free carnitine and acycarnitine in mouse serum and tissues. British Journal of Pharmacology, 103, 1179-1183.
9. Chace, D. H., Hillman, S. L., van Hove, J. L. K., & Naylor, E. W. (1997). Rapid diagnosis of MCAD deficiency: Quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clinical Chemistry, 43, 2106-2113.
10. Ford, D. A., Han, X., Horner, C. C., & Gross, R. W. (1996). Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: Metabolic compartmentalization of produces of fatty acyl chain elongation in the acylcarnitine pool. Biochemistry, 35, 7903-7909.
11. French, T. J., Goode, A. W., & Sugden, M. C. (1986). Ischaemia and tissue pyruvate activities in the rat: a comparison of the effects of cervical dislocation and pentobarbital anesthesia. Biochemistry International, 13, 843-852.
12. Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., et al. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature, 464, 121-125.
13. Jensen, M. V., Joseph, J. W., Olga Ilkayeva, O., Burgess, S., Lu, D., Ronnebaum, S. M., et al. (2006). Compensatory responses to pyruvate carboxylase suppression in Islet β-cells. Preservation of glucose-stimulated insulin secretion. Journal of Biological Chemistry, 281, 22342-22351.
14. Kawaguchi, H., Hirakawa, K., Miyauchi, K., Koike, K., Ohno, Y., & Sakamoto, A. (2010). Pattern recognition analysis of proton nuclear magnetic resonance spectra of brain tissue extracts from rats anesthetized with propofol or Isoflurane. PLoS One, 5, e11172.
15. Kien, C. L., Everingham, K. I., Stevens, R. D., Fukagawa, N. K., & Muoio, D. M. (2011). Short-term effects of dietary fatty acids on muscle lipid composition and serum acylcarnitine profile in human subjects. Obesity, 19, 305-311.
16. Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., et al. (2008). Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metabolism, 7, 45-56.
17. Lin, C. Y., Wu, H., Tjeerdema, R. S., & Viant, M. R. (2007). Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics, 3, 55-67.
18. Ljubkovic, M., Mio, Y., Marinovic, J., Stadnicka, A., Warltier, D. C., Bosnjak, Z. J., et al. (2007). Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. American Journal of Physiology-Cell Physiology, 292, C1583-C1590.
19. 2β, precipitating ventricular tachyarrhythmias in transgenic mice. Journal of Biological Chemistry, 278, 22231-22236.
20. Masson, P., Alves, A. C., Ebbels, T. M. D., Nicholson, J. K., & Want, E. J. (2010). Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. Analytical Chemistry, 82, 7779-7786.
21. Mendrick, D. L., & Schnackenberg, L. (2009). Genomic and metabolomics advances in the identification of disease and adverse event biomarkers. Biomarkers in Medicine, 3, 605-615.
22. Millington, D. S., Kodo, N., Norwood, D. L., & Roe, C. R. (1990). Tandem mass spectrometry: A new method for acycarntine profling with potential for neonatal screening for inborn errors of metabolism. Journal of Inherited Metabolic Disease, 13, 321-324.
23. Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., et al. (2009). Metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism, 9, 311-326.
24. Nicholson, J. K., & Lindon, J. C. (2008). Metabonomics. Nature, 455, 1054-1056.
25. Park, E.-S., Daily, J. W., & Sachan, D. S. (2001). Anesthetics and cardiocentesis increased urinary carnitine excretion in rats and guinea pigs. Nutrition Research, 21, 531-540.
26. Ramsay, R. R., & Zammit, V. A. (2004). Carnitine acyltransferases and their influence on CoA pools in health and disease. Molecular Aspects of Medicine, 25, 475-493.
27. Robertson, D. G., Reily, M. D., & Baker, D. (2007). Metabonomics in pharmaceutical discovery and development. Journal of Proteome Research, 6, 526-539.
28. Sedlic, F., Pravdic, D., Hirata, N., Mio, Y., Sepac, A., Camara, A. K., et al. (2010). Monitoring mitochondrial electron fluxes using NAD(P)H-flavoprotein fluormetry reveals complex action of isoflurane on cardiomyocytes. Biochimica et Biophysica Acta, 1797, 1749-1758.
29. Seifert, E. L., Fiehn, O., Bezaire, V., Bickel, D. R., Wohlgemuth, G., Adams, S. H., et al. (2010). Long-chain fatty acid combustion rate is associated with unique metabolite profiles in skeletal muscle mitochondria. PLoS One, 5, e9834.
30. Sewell, A. C., & Böhles, H. J. (1995). Acylcarnitines in intermediary metabolism. European Journal of Pediatrics, 154, 871-877.
31. Son, N. H., Yu, S., Tuinei, J., Arai, K., Hamai, H., Homma, S., et al. (2010). PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation. Journal of Clinical Investigation, 120, 3443-3454.
32. Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457, 910-914.
33. Su, X., Han, X., Mancuso, D. J., Abendschein, D. R., & Gross, R. W. (2005). Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: Identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics. Biochemistry, 44, 5234-5245.
34. Turer, A. T., Stevens, R. D., Bain, J. R., Muehlbauer, M. J., van der Westhuizen, J., Mathew, J. P., et al. (2009). Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation, 119, 1736-1746.
35. van Vlies, N., Tan, L., Overmars, H., Bootsma, A. H., Kulik, W., Wanders, R. J. A., et al. (2005). Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse. Biochemical Journal, 387, 185-193.
36. Wang, L., Ko, K. W. S., Lucchinetti, E., Zhang, L., Troxler, H., Hersberger, M., et al. (2010). Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. Anesthesiology, 113, 541-551.
37. Yanes, O., Clark, J., Wong, D. M., Patti, G. J., Sánchez-Ruiz, A., Benton, H. P., et al. (2010). Metabolic oxidation regulates embryonic stem cell differentiation. Nature Chemical Biology, 6, 411-417.